Back to Search
Start Over
IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.
- Source :
- Nature Immunology; Mar2015, Vol. 16 Issue 3, p286-295, 10p, 7 Graphs
- Publication Year :
- 2015
-
Abstract
- Interleukin 17 (IL-17)-producing helper T cells (T<subscript>H</subscript>17 cells) and CD4<superscript>+</superscript> inducible regulatory T cells (iT<subscript>reg</subscript> cells) emerge from an overlapping developmental program. In the intestines, the vitamin A metabolite retinoic acid (RA) is produced at steady state and acts as an important cofactor to induce iT<subscript>reg</subscript> cell development while potently inhibiting T<subscript>H</subscript>17 cell development. Here we found that IL-1 was needed to fully override RA-mediated expression of the transcription factor Foxp3 and induce protective T<subscript>H</subscript>17 cell responses. By repressing expression of the negative regulator SOCS3 dependent on the transcription factor NF-κB, IL-1 increased the amplitude and duration of phosphorylation of the transcription factor STAT3 induced by T<subscript>H</subscript>17-polarizing cytokines, which led to an altered balance in the binding of STAT3 and STAT5 to shared consensus sequences in developing T cells. Thus, IL-1 signaling modulated STAT activation downstream of cytokine receptors differently to control the T<subscript>H</subscript>17 cell-iT<subscript>reg</subscript> cell developmental fate. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15292908
- Volume :
- 16
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Nature Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 101025256
- Full Text :
- https://doi.org/10.1038/ni.3099